Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8ZBS

Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (in complex with vincristine)

Summary for 8ZBS
Entry DOI10.2210/pdb8zbs/pdb
EMDB information39909
DescriptorATP-binding cassette sub-family C member 4, vincristine, PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER, ... (4 entities in total)
Functional Keywordsatp-binding cassette sub-family c member 4, multidrug resistance proteins (mrps), multidrug-resistance (mdr), transport protein, membrane protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight154089.51
Authors
Xie, Z.,Long, F. (deposition date: 2024-04-27, release date: 2025-04-09)
Primary citationXie, Z.,Lv, J.,Huang, W.,Wu, Z.,Zhu, R.,Deng, Z.,Long, F.
Structural basis for the reversal of human MRP4-mediated multidrug resistance by lapatinib.
Cell Rep, 44:115466-115466, 2025
Cited by
PubMed Abstract: Multidrug resistance proteins (MRPs) are one of the major mechanisms for developing cancer drug resistance. Human MRP4 (hMRP4) plays an important role in various chemotherapy-resistant cancers. Here, we show hMRP4 mediates the resistance of a broad spectrum of antitumor reagents in the cultured tumor cells, among which the cell resistance to vincristine and 5-fluorouracil is rescued by supplementing a tyrosinase inhibitor, lapatinib. The cryoelectron microscopy (cryo-EM) structures of hMRP4 in the substrate- or inhibitor-bound form are determined. Although lapatinib shares partial binding sites with vincristine and 5-fluorouracil using a similar set of crucial residues located in the central cavity of hMRP4, the high binding affinity of lapatinib and its unique binding mode with transmembrane helices TM2 and TM12 inside the pathway tunnel prohibit hMRP4 from structural transition between intermediate states during drug translocation. This study provides mechanistic insights into the therapeutical potential of lapatinib in combating hMRP4-mediated MDR.
PubMed: 40138312
DOI: 10.1016/j.celrep.2025.115466
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.96 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon